Robert S. Landsman

Array ( [id] => 6595194 [patent_doc_number] => 20100062456 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-11 [patent_title] => 'T2R, A NOVEL FAMILY OF TASTE RECEPTORS' [patent_app_type] => utility [patent_app_number] => 12/544854 [patent_app_country] => US [patent_app_date] => 2009-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 82 [patent_figures_cnt] => 82 [patent_no_of_words] => 42306 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0062/20100062456.pdf [firstpage_image] =>[orig_patent_app_number] => 12544854 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8435370 [patent_doc_number] => 08283138 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-09 [patent_title] => 'Method for the high level expression of active tumor necrosis receptor family member immunoglobulin fusion proteins' [patent_app_type] => utility [patent_app_number] => 12/542614 [patent_app_country] => US [patent_app_date] => 2009-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 21 [patent_no_of_words] => 10036 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12542614 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6167913 [patent_doc_number] => 20110162095 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-30 [patent_title] => 'TNFSF Single Chain Molecules' [patent_app_type] => utility [patent_app_number] => 13/055109 [patent_app_country] => US [patent_app_date] => 2009-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 13682 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0162/20110162095.pdf [firstpage_image] =>[orig_patent_app_number] => 13055109 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6589148 [patent_doc_number] => 20100130402 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-27 [patent_title] => 'Biomarkers for insulin resistance and beta-cell dysfunction' [patent_app_type] => utility [patent_app_number] => 12/505367 [patent_app_country] => US [patent_app_date] => 2009-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 20072 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20100130402.pdf [firstpage_image] =>[orig_patent_app_number] => 12505367 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8227284 [patent_doc_number] => 20120141495 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-07 [patent_title] => 'METHOD FOR SUPPRESSING TUMOR GROWTH BY BLOCKING FIBROBLAST GROWTH FACTOR RECEPTOR, AND METHOD FOR DIAGNOSING MALIGNANT NEOPLASMS' [patent_app_type] => utility [patent_app_number] => 13/261076 [patent_app_country] => US [patent_app_date] => 2009-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 6404 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13261076 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9166879 [patent_doc_number] => 08592557 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-11-26 [patent_title] => 'Multimeric TNF receptor fusion proteins and nucleic acids encoding same' [patent_app_type] => utility [patent_app_number] => 12/999607 [patent_app_country] => US [patent_app_date] => 2009-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 8 [patent_no_of_words] => 5409 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12999607 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8760254 [patent_doc_number] => 08420775 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-16 [patent_title] => 'Polypeptides and methods for modulating D1-D2 dopamine receptor interaction and function' [patent_app_type] => utility [patent_app_number] => 12/997813 [patent_app_country] => US [patent_app_date] => 2009-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 14618 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12997813 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8103507 [patent_doc_number] => 08153398 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-10 [patent_title] => 'Polynucleotides encoding signal peptide-containing molecules' [patent_app_type] => utility [patent_app_number] => 12/457389 [patent_app_country] => US [patent_app_date] => 2009-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 43979 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/153/08153398.pdf [firstpage_image] =>[orig_patent_app_number] => 12457389 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9311262 [patent_doc_number] => 08652478 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-02-18 [patent_title] => 'Method for treating cancer by administering antibody to ephrin type-A receptor 7' [patent_app_type] => utility [patent_app_number] => 12/997204 [patent_app_country] => US [patent_app_date] => 2009-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 51413 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12997204 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6113288 [patent_doc_number] => 20110190273 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-04 [patent_title] => 'METHODS AND COMPOSITIONS IN THE TREATMENT OF CORONAVIRUSES' [patent_app_type] => utility [patent_app_number] => 12/996453 [patent_app_country] => US [patent_app_date] => 2009-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9528 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20110190273.pdf [firstpage_image] =>[orig_patent_app_number] => 12996453 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8214239 [patent_doc_number] => 08193151 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-06-05 [patent_title] => 'Methods for treating atrial or ventricular arrhythmias' [patent_app_type] => utility [patent_app_number] => 12/430595 [patent_app_country] => US [patent_app_date] => 2009-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 28 [patent_no_of_words] => 18682 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/193/08193151.pdf [firstpage_image] =>[orig_patent_app_number] => 12430595 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6497864 [patent_doc_number] => 20100010195 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-14 [patent_title] => 'Novel tumor necrosis factor receptor homolog and nucleic acids encoding the same' [patent_app_type] => utility [patent_app_number] => 12/384695 [patent_app_country] => US [patent_app_date] => 2009-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 22837 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20100010195.pdf [firstpage_image] =>[orig_patent_app_number] => 12384695 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9238999 [patent_doc_number] => 08603790 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-10 [patent_title] => 'Systems, methods and compositions for optical stimulation of target cells' [patent_app_type] => utility [patent_app_number] => 12/988567 [patent_app_country] => US [patent_app_date] => 2009-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 18741 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12988567 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7702845 [patent_doc_number] => 08088599 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-03 [patent_title] => 'Nucleic acids encoding genetically modified tissue factor pathway inhibitor (TFPI) and method of making the same' [patent_app_type] => utility [patent_app_number] => 12/407529 [patent_app_country] => US [patent_app_date] => 2009-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 6625 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/088/08088599.pdf [firstpage_image] =>[orig_patent_app_number] => 12407529 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9888970 [patent_doc_number] => 08975225 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-03-10 [patent_title] => 'Method for inhibiting growth of chondrocytes in a subject by inhibiting IGF-1' [patent_app_type] => utility [patent_app_number] => 13/257347 [patent_app_country] => US [patent_app_date] => 2009-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6371 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13257347 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5385204 [patent_doc_number] => 20090226449 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-10 [patent_title] => 'Novel 18607, 15603, 69318, 12303, 48000, 52920, 5433, 38554, 57301, 58324, 55063, 52991, 59914, 59921, and 33751 molecules and uses therefor' [patent_app_type] => utility [patent_app_number] => 12/381748 [patent_app_country] => US [patent_app_date] => 2009-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 112080 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20090226449.pdf [firstpage_image] =>[orig_patent_app_number] => 12381748 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5385203 [patent_doc_number] => 20090226448 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-10 [patent_title] => 'Novel 18607, 15603, 69318, 12303, 48000, 52920, 5433, 38554, 57301, 58324, 55063, 52991, 59914, 59921 and 33751 molecules and uses therefor' [patent_app_type] => utility [patent_app_number] => 12/381747 [patent_app_country] => US [patent_app_date] => 2009-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 112080 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20090226448.pdf [firstpage_image] =>[orig_patent_app_number] => 12381747 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7807157 [patent_doc_number] => 20120058110 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-08 [patent_title] => ' Method for Predicting the Responsiveness to an Anti-TNF Alpha Antibody Treatment' [patent_app_type] => utility [patent_app_number] => 13/255291 [patent_app_country] => US [patent_app_date] => 2009-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6790 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20120058110.pdf [firstpage_image] =>[orig_patent_app_number] => 13255291 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4522326 [patent_doc_number] => 07951549 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-31 [patent_title] => 'Methods for the identification of agents that inhibit mesenchymal-like tumor cells or their formation' [patent_app_type] => utility [patent_app_number] => 12/381082 [patent_app_country] => US [patent_app_date] => 2009-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 26 [patent_no_of_words] => 39931 [patent_no_of_claims] => 93 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/951/07951549.pdf [firstpage_image] =>[orig_patent_app_number] => 12381082 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5380249 [patent_doc_number] => 20090192088 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-30 [patent_title] => 'Vascular Endothelial Growth Factor 2' [patent_app_type] => utility [patent_app_number] => 12/396033 [patent_app_country] => US [patent_app_date] => 2009-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 8813 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20090192088.pdf [firstpage_image] =>[orig_patent_app_number] => 12396033 [rel_patent_id] =>[rel_patent_doc_number] =>)